Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE5206.556.75 (+0.13 %)

PREV CLOSE ( ) 5199.80

OPEN PRICE ( ) 5227.45

BID PRICE (QTY) 5201.05 (2)

OFFER PRICE (QTY) 5227.95 (5)

VOLUME 31

TODAY'S LOW / HIGH ( )5206.55 5227.45

52 WK LOW / HIGH ( )4360.3 5954

NSE5218.508.5 (+0.16 %)

PREV CLOSE( ) 5210.00

OPEN PRICE ( ) 5210.00

BID PRICE (QTY) 5207.00 (1)

OFFER PRICE (QTY) 5214.50 (1)

VOLUME 426

TODAY'S LOW / HIGH( ) 5200.00 5248.00

52 WK LOW / HIGH ( )4211.55 5894.5

Select year

Particulars

Dec 2024

Dec 2023

Operational & Financial Ratios

Earnings Per Share (Rs)

78.70

824.50

CEPS(Rs)

80.65

833.50

DPS(Rs)

55.00

50.00

Book NAV/Share(Rs)

118.26

923.00

Tax Rate(%)

26.66

24.81

Margin Ratios

Core EBITDA Margin(%)

35.76

37.87

EBIT Margin(%)

33.13

37.96

Pre Tax Margin(%)

32.62

37.96

PAT Margin (%)

23.92

28.54

Cash Profit Margin (%)

24.51

28.86

Performance Ratios

ROA(%)

40.67

48.01

ROE(%)

79.28

89.33

ROCE(%)

104.33

105.64

Asset Turnover(x)

1.70

1.68

Sales/Fixed Asset(x)

29.62

51.58

Working Capital/Sales(x)

2.90

2.81

Efficiency Ratios

Fixed Capital/Sales(x)

0.03

0.02

Receivable days

10.93

19.97

Inventory Days

33.16

61.03

Payable days

127.78

144.17

Valuation Parameters

PER(x)

62.61

0.00

PCE(x)

61.09

0.00

Price/Book(x)

41.66

0.00

Yield(%)

1.12

EV/Net Sales(x)

15.19

0.00

EV/Core EBITDA(x)

38.81

0.00

EV/EBIT(x)

43.90

0.00

EV/CE(x)

40.31

0.00

M Cap / Sales

15.64

0.00

Growth Ratio

Net Sales Growth(%)

30.45

0.00

Core EBITDA Growth(%)

27.23

0.00

EBIT Growth(%)

14.32

0.00

PAT Growth(%)

9.76

0.00

EPS Growth(%)

-90.46

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.00

Current Ratio(x)

2.04

2.58

Quick Ratio(x)

1.87

1.84

Interest Cover(x)

64.28

Total Debt/Mcap(x)

0.00